Evaluation of Long-Term Safety of Pirfenidone (Esbriet) in Participants With Idiopathic Pulmonary Fibrosis (IPF)

Clinical trial NCT02699879 · COMPLETED

Trial details

NCT number: NCT02699879
Sponsor: Hoffmann-La Roche
Status: COMPLETED
Study type: OBSERVATIONAL

Idiopathic Pulmonary Fibrosis

Start date: 2012-02-16
Primary completion: 2016-09-15
Enrollment: 1009

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.